This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Aging/ Geriatrics  • Health Policy  • Ophthalmology, Other  • Prognosis/ Outcomes  • Facial Plastic Surgery  • Oculoplastic Surgery  • Alert me on articles by topic  Social Bookmarking   What's this?

The 2008 Wendell Hughes Lecture

George B. Bartley, MD

Arch Ophthalmol. 2009;127(7):932-935.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

It is a great privilege to present the 39th Annual Wendell Hughes Lecture. Nearly all of the previous honorees have focused on technical aspects of oculoplastic surgery or the curious collection of diseases and dysfunctions that, when cobbled together, constitute our unique subspecialty. So, when given the opportunity to share a few thoughts from this podium, my first instinct was to comment on one of the clinical topics such as Graves ophthalmopathy or orbital tumors that have intrigued me over the years. But I would have little new to share with this audience given that my focus over the past several years has been on budgets rather than Botox, regulations rather than Restylane, liver transplants rather than orbital implants, hospital construction rather than Hughes reconstruction. Therefore, I decided to share a personal perspective on what I’ve observed as my career has migrated from the operating room . . . [Full Text of this Article]

AUTHOR INFORMATION


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?